A Contemporary Review of the Treatment Landscape and the Role of Predictive and Prognostic Biomarkers in Pancreatic Adenocarcinoma Por Irene S. Yu, Winson Y. Cheung

Obter o texto integral

Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy Por Irene S. Yu, Winson Y. Cheung

Obter o texto integral

The Expanding Role of Systemic Therapy in the Management of Hepatocellular Carcinoma Por Omar Abdel-Rahman, Winson Y. Cheung

Obter o texto integral

Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases Por Omar Abdel-Rahman, Winson Y. Cheung

Obter o texto integral

Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective Por Allison Wills, Arif Mitha, Winson Y. Cheung

Obter o texto integral

Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada Por Philip Q. Ding, Aastha Dolley, Winson Y. Cheung

Obter o texto integral

Examining external control arms in oncology: A scoping review of applications to date Por Eliya Farah, Matthew Kenney, Matthew T. Warkentin, Winson Y. Cheung, Darren R. Brenner

Obter o texto integral

Outcomes of hepatocellular carcinoma patients treated in the lenvatinib and immunotherapy era (2018–2021) compared to the sorafenib era (2008–2018) Por Chloe A. Lim, Carla P. Amaro, Philip Q. Ding, Winson Y. Cheung, Vincent C. Tam

Obter o texto integral

Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for <i>EGFR</i> Mutation-Positive Patients Treated with First-Line Osimertinib Por Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt, Adrian Box, Winson Y. Cheung, Vishal Navani

Obter o texto integral

Text analysis framework for identifying mutations among non-small cell lung cancer patients from laboratory data Por Amman Yusuf, Devon J. Boyne, Dylan E. O’Sullivan, Darren R. Brenner, Winson Y. Cheung, Imran Mirza, Tamer N. Jarada

Obter o texto integral

Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta Por Winson Y. Cheung, Chantelle Carbonell, Vishal Navani, Randeep S. Sangha, Emmanuel M. Ewara, Julia Elia-Pacitti, Sandra Iczkovitz, Tamer N. Jarada, Matthew T. Warkentin

Obter o texto integral

Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer Por Annalise G. Abbott, Annalise G. Abbott, Daniel E. Meyers, Daniel E. Meyers, Golpira Elmi-Assadzadeh, Igor Stukalin, Igor Stukalin, Alessandro Marro, Shannon K. T. Puloski, Shannon K. T. Puloski, Shannon K. T. Puloski, Don G. Morris, Don G. Morris, Winson Y. Cheung, Winson Y. Cheung, Michael J. Monument, Michael J. Monument, Michael J. Monument

Obter o texto integral

Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis Por Devon J. Boyne, Dylan E. O'Sullivan, Emily V. Heer, Robert J. Hilsden, Tolulope T. Sajobi, Winson Y. Cheung, Darren R. Brenner, Christine M. Friedenreich

Obter o texto integral

Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Early-Stage Non-Small-Cell Lung Cancer Por Dylan E. O’Sullivan, Devon J. Boyne, Chelsea Ford-Sahibzada, Jessica A. Inskip, Christopher J. Smith, Kaushik Sripada, Darren R. Brenner, Winson Y. Cheung

Obter o texto integral

Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, a... Por Andrea S. Fung, Vincent C. Tam, Daniel E. Meyers, Hao‐Wen Sim, Jennifer J. Knox, Valeriya Zaborska, Janine Davies, Yoo‐Joung Ko, Eugene Batuyong, Haider Samawi, Winson Y. Cheung, Richard Lee‐Ying

Obter o texto integral

Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database Por Haider H. Samawi, Hao‐Wen Sim, Kelvin K. Chan, Mohammad A. Alghamdi, Richard M. Lee‐Ying, Jennifer J. Knox, Parneet Gill, Adriana Romagnino, Eugene Batuyong, Yoo‐Joung Ko, Janine M. Davies, Howard J. Lim, Winson Y. Cheung, Vincent C. Tam, the CHORD Consortium

Obter o texto integral

Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada Por Qi Guan, Suriya J. Aktar, Reka E. Pataky, Mariet Mathew Stephen, Maud Marques, Karen Gambaro, Kahina Rachedi, Katharina Forster, Samara Strub, David Stock, Louis de Léséleuc, Winson Y. Cheung, Stuart Peacock, Christie Farrer, Scott Gavura, Mina Tadrous, Robert C. Grant, Kelvin K. W. Chan

Obter o texto integral